Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandins and platelet aggregation

J B Smith

    Acta Medica Scandinavica. Supplementum
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Prostaglandins like prostacyclin (PGI2) and thromboxane A2 play key roles in blood vessel and platelet function. Research explores their potential in managing conditions like coronary ischemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ubiquitination of protein kinase C-alpha and degradation by the proteasome.

    The Journal of biological chemistry·1996
    Same author

    The glucocorticoid attenuated response genes GARG-16, GARG-39, and GARG-49/IRG2 encode inducible proteins containing multiple tetratricopeptide repeat domains.

    Archives of biochemistry and biophysics·1996
    Same author

    Extracellular ATP increases cytosolic calcium in cultured rat renal arterial smooth muscle cells.

    Clinical and experimental pharmacology & physiology·1996
    Same author

    Calcium bioavailability from bovine milk and dairy products in premenopausal women using intrinsic and extrinsic labeling techniques.

    The Journal of nutrition·1996
    Same author

    Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa.

    Journal of the American Academy of Dermatology·1996
    Same author

    Cutaneous manifestations and consequences of smoking.

    Journal of the American Academy of Dermatology·1996
    Same journal

    Giving life, giving death: ethical problems of high-technology medicine.

    Acta medica Scandinavica. Supplementum·1988
    Same journal

    Potential importance of the muscles for the development of insulin resistance in obesity.

    Acta medica Scandinavica. Supplementum·1988
    Same journal

    Potential role of adipose tissue for the development of insulin resistance in obesity.

    Acta medica Scandinavica. Supplementum·1988
    Same journal

    Mechanisms associating body fat distribution to glucose intolerance and diabetes mellitus: window with a view.

    Acta medica Scandinavica. Supplementum·1988
    Same journal

    Physical training and changes in regional adipose tissue distribution.

    Acta medica Scandinavica. Supplementum·1988
    Same journal

    Hormonal abnormalities in obesity.

    Acta medica Scandinavica. Supplementum·1988
    See all related articles

    Area of Science:

    • Biochemistry
    • Cardiovascular Physiology

    Background:

    • Prostaglandins, arachidonic acid derivatives, influence platelet aggregation and blood vessel tone.
    • Prostacyclin (PGI2) is a vasodilator and platelet aggregation inhibitor, but its circulating levels are low.
    • Thromboxane A2 (TXA2) is a vasoconstrictor implicated in coronary ischemia.

    Purpose of the Study:

    • To investigate the roles of various prostaglandins in cardiovascular function.
    • To explore potential methods for increasing beneficial prostacyclin levels.
    • To understand the contribution of thromboxane A2 to ischemic events.

    Main Methods:

    • Review of existing literature on prostaglandin synthesis and function.
    • Analysis of studies investigating prostacyclin (PGI2) and thromboxane A2 (TXA2) in cardiovascular contexts.

    Related Experiment Videos

  • Examination of evidence for the effects of stable prostaglandin analogues.

    • Main Results:

    • Prostacyclin (PGI2) and prostaglandin D2 (PGD2) inhibit platelet aggregation.
    • Thromboxane A2 (TXA2) may exacerbate ischemic damage through vasoconstriction and platelet aggregation.
    • Aspirin inhibits both prostacyclin and thromboxane formation.

    Conclusions:

    • Prostaglandins exhibit complex, often opposing, effects on vascular and platelet activity.
    • Further research is needed to understand how to modulate prostaglandin levels for therapeutic benefit.
    • Thromboxane A2's role in coronary ischemia warrants continued investigation.